1. Home
  2. FSBC vs ESPR Comparison

FSBC vs ESPR Comparison

Compare FSBC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Star Bancorp

FSBC

Five Star Bancorp

N/A

Current Price

$37.72

Market Cap

821.1M

Sector

Finance

ML Signal

N/A

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

N/A

Current Price

$3.04

Market Cap

793.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSBC
ESPR
Founded
2002
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.1M
793.7M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
FSBC
ESPR
Price
$37.72
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$40.75
$8.25
AVG Volume (30 Days)
53.4K
3.4M
Earning Date
01-01-0001
04-02-2026
Dividend Yield
2.65%
N/A
EPS Growth
28.32
86.21
EPS
2.90
N/A
Revenue
N/A
$332,314,000.00
Revenue This Year
$29.27
$27.35
Revenue Next Year
$12.35
N/A
P/E Ratio
$13.01
N/A
Revenue Growth
N/A
185.66
52 Week Low
$22.22
$0.73
52 Week High
$42.26
$4.18

Technical Indicators

Market Signals
Indicator
FSBC
ESPR
Relative Strength Index (RSI) 35.75 41.62
Support Level $36.20 $2.36
Resistance Level $38.25 $3.02
Average True Range (ATR) 1.51 0.17
MACD -0.38 -0.06
Stochastic Oscillator 27.82 34.93

Price Performance

Historical Comparison
FSBC
ESPR

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: